Search Results

Trapidil 100 mg  | Purity Not Available

TargetMol

Trapidil is a coronary vasodilator agent. It was originally developed as a vasodilator and anti-platelet agent and has been used to treat patients with ischemic coronary heart, liver, and kidney disease.

More Information Supplier Page

Trapidil 200 mg  | Purity Not Available

TargetMol

Trapidil is a coronary vasodilator agent. It was originally developed as a vasodilator and anti-platelet agent and has been used to treat patients with ischemic coronary heart, liver, and kidney disease.

More Information Supplier Page

Riociguat 5 mg  | 99.91%

TargetMol

Riociguat is a stimulator of guanylate cyclase which causes relaxation of vascular smooth muscle and is used to treat severe pulmonary arterial hypertension.

More Information Supplier Page

Riociguat 50 mg  | 99.91%

TargetMol

Riociguat is a stimulator of guanylate cyclase which causes relaxation of vascular smooth muscle and is used to treat severe pulmonary arterial hypertension.

More Information Supplier Page

Riociguat 10 mg  | 99.91%

TargetMol

Riociguat is a stimulator of guanylate cyclase which causes relaxation of vascular smooth muscle and is used to treat severe pulmonary arterial hypertension.

More Information Supplier Page

Riociguat 100 mg  | 99.91%

TargetMol

Riociguat is a stimulator of guanylate cyclase which causes relaxation of vascular smooth muscle and is used to treat severe pulmonary arterial hypertension.

More Information Supplier Page

Resiquimod 50 mg  | 99.81%

TargetMol

Resiquimod is an imidazoquinoline amine and Toll-like receptor (TLR) agonist with potential immune response modifying activity. Resiquimod exerts its effect through the TLR signaling pathway by binding to and activating TLR7 and 8 mainly on dendritic cells, macrophages, and B-lymphocytes. This induces the nuclear translocation of the transcription activator NF-kB as well as activation of […]

More Information Supplier Page